Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

6.560
-0.140-2.09%
Volume:1.73M
Turnover:11.30M
Market Cap:4.57B
PE:9.65
High:6.670
Open:6.670
Low:6.460
Close:6.700
52wk High:9.460
52wk Low:4.895
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:1.61
T/O Rate:0.89%
Dividend:0.27
Dividend Rate:4.16%
EPS(LYR):0.680
ROE:7.59%
ROA:3.06%
PB:0.78
PE(LYR):9.65
PS:0.47

Loading ...

SHANDONG XINHUA (00719) Unit Secures Drug Registration Certificate for Ibuprofen Granules

Stock News
·
Yesterday

Shandong Xinhua (00719) Secures MAH Status for Ezetimibe Tablets, Targeting China’s RMB 810.00 Million Hypercholesterolemia Market

Bulletin Express
·
Mar 16

Shandong Xinhua Pharmaceutical Receives Approval for Ezetimibe Tablet Holder Transfer

Stock News
·
Mar 16

Shandong Xinhua Pharma (00719) Sets 27 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal

Bulletin Express
·
Mar 13

SHANDONG XINHUA (00719) Announces Approval for Entacapone Tablets

Bulletin Express
·
Mar 04

SHANDONG XINHUA (00719) Secures Approval for Subsidiary’s Saxagliptin and Metformin Hydrochloride Sustained-release Tablets

Bulletin Express
·
Mar 04

SHANDONG XINHUA's Subsidiary Obtains Drug Registration Certificate for Saxagliptin and Metformin Extended-Release Tablets

Stock News
·
Mar 04

Shandong Xinhua Pharmaceutical Granted Drug Registration Certificate for Entacapone Tablets

Stock News
·
Mar 04

Shandong Xinhua Pharmaceutical (00719): Listing Information

Bulletin Express
·
Mar 02

Xinhua Pharmaceutical Gets Registration Certificate for Osteoarthritis Drug in China

MT Newswires Live
·
Feb 09

Shandong Xinhua Pharmaceutical (000756) Obtains Drug Registration Certificate for Glucosamine Sulfate Capsules

Bulletin Express
·
Feb 09

SHANDONG XINHUA Secures Drug Registration Certificate for Glucosamine Sulfate Capsules

Stock News
·
Feb 09

Shandong Xinhua Pharmaceutical Terminates Equity Acquisition Talks With NovoSana

MT Newswires Live
·
Feb 09

Shandong Xinhua Pharmaceutical (00719) Terminates Equity Acquisition Intention with NovoSana (Europe) B.V.

Bulletin Express
·
Feb 06

Shandong Xinhua Pharmaceutical Calls Off Planned Acquisition of Nuoya Shengnuo (Taicang) Stake

Stock News
·
Feb 06

Shandong Xinhua (00719) Announces January 2026 Share Capital Movements

Bulletin Express
·
Feb 02

Shandong Xinhua Pharmaceutical (00719) Cancels Total of 1.057 Million Granted but Unexercised Stock Options

Stock News
·
Jan 20

SHANDONG XINHUA (00719) Grants 6.9069 Million A-Shares Under 2021 Stock Option Incentive Plan

Stock News
·
Jan 14

SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Phloroglucinol Injection

Stock News
·
Dec 29, 2025

Xinhua Pharmaceutical Gets Registration Certificate for Influenza Drug in China

MT Newswires Live
·
Dec 23, 2025